These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23826749)

  • 1. Monoclonal antibody humanness score and its applications.
    Gao SH; Huang K; Tu H; Adler AS
    BMC Biotechnol; 2013 Jul; 13():55. PubMed ID: 23826749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The humanness of macaque antibody sequences.
    Thullier P; Huish O; Pelat T; Martin AC
    J Mol Biol; 2010 Mar; 396(5):1439-50. PubMed ID: 20043919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing the "degree of humanness" of antibody sequences.
    Abhinandan KR; Martin AC
    J Mol Biol; 2007 Jun; 369(3):852-62. PubMed ID: 17442342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular immunology approach to antibody humanization and functional optimization.
    Lazar GA; Desjarlais JR; Jacinto J; Karki S; Hammond PW
    Mol Immunol; 2007 Mar; 44(8):1986-98. PubMed ID: 17079018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanization and Simultaneous Optimization of Monoclonal Antibody.
    Kuramochi T; Igawa T; Tsunoda H; Hattori K
    Methods Mol Biol; 2019; 1904():213-230. PubMed ID: 30539472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanization of Antibodies using a Statistical Inference Approach.
    Clavero-Álvarez A; Di Mambro T; Perez-Gaviro S; Magnani M; Bruscolini P
    Sci Rep; 2018 Oct; 8(1):14820. PubMed ID: 30287940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computationally driven antibody engineering enables simultaneous humanization and thermostabilization.
    Choi Y; Ndong C; Griswold KE; Bailey-Kellogg C
    Protein Eng Des Sel; 2016 Oct; 29(10):419-426. PubMed ID: 27334453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BioPhi: A platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learning.
    Prihoda D; Maamary J; Waight A; Juan V; Fayadat-Dilman L; Svozil D; Bitton DA
    MAbs; 2022; 14(1):2020203. PubMed ID: 35133949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of immunogenicity for humanized and full human therapeutic antibodies.
    Liang S; Zhang C
    PLoS One; 2020; 15(8):e0238150. PubMed ID: 32866159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel humanized anti-CD20 antibody with potent anti-tumor activity against non-Hodgkin's lymphoma.
    Zhang H; Song L; Ye H; Hu L; Liang W; Liu D
    Cell Physiol Biochem; 2013; 32(3):645-54. PubMed ID: 24022075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
    De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
    J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine.
    Carrasco-Triguero M; Yi JH; Dere R; Qiu ZJ; Lei C; Li Y; Mahood C; Wang B; Leipold D; Poon KA; Kaur S
    Bioanalysis; 2013 May; 5(9):1007-23. PubMed ID: 23641693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proteomics approach for the identification and cloning of monoclonal antibodies from serum.
    Cheung WC; Beausoleil SA; Zhang X; Sato S; Schieferl SM; Wieler JS; Beaudet JG; Ramenani RK; Popova L; Comb MJ; Rush J; Polakiewicz RD
    Nat Biotechnol; 2012 Mar; 30(5):447-52. PubMed ID: 22446692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of humanized antibodies: from anti-Tac to Zenapax.
    Tsurushita N; Hinton PR; Kumar S
    Methods; 2005 May; 36(1):69-83. PubMed ID: 15848076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the Epitope Regions of Therapeutic Antibodies Based on Structure Descriptors.
    Qiu J; Qiu T; Huang Y; Cao Z
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody.
    Covaceuszach S; Marinelli S; Krastanova I; Ugolini G; Pavone F; Lamba D; Cattaneo A
    PLoS One; 2012; 7(3):e32212. PubMed ID: 22403636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif.
    Baek DS; Kim YS
    Biochem Biophys Res Commun; 2015 Jul; 463(3):414-20. PubMed ID: 26036575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies.
    Kolbinger F; Saldanha J; Hardman N; Bendig MM
    Protein Eng; 1993 Nov; 6(8):971-80. PubMed ID: 8309946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural correlates of an anticarcinoma antibody: identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only.
    Tamura M; Milenic DE; Iwahashi M; Padlan E; Schlom J; Kashmiri SV
    J Immunol; 2000 Feb; 164(3):1432-41. PubMed ID: 10640759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering the variable region of therapeutic IgG antibodies.
    Igawa T; Tsunoda H; Kuramochi T; Sampei Z; Ishii S; Hattori K
    MAbs; 2011; 3(3):243-52. PubMed ID: 21406966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.